Context: Obesity is a global epidemic, and there is a focus on identifying markers of obesity in children with a view to prevention.
T he concept of fuel-mediated teratogenesis, as proposed by Freinkel (1) in his 1980 Banting Lecture, postulated that altered fuel metabolism during pregnancy had a long-lasting metabolic effect on the offspring. Although in the intervening years, the focus has largely been on maternal glucose as the principal fetal fuel, Herrera et al. (2) have observed that triglycerides (TGs) are taken up by the placenta and hydrolyzed to release free fatty acids in the fetus. Furthermore, the latter part of pregnancy is associated with a substantial hyperlipidemia, including hypercholesterolemia and hypertriglyceridemia.
The relationships of maternal lipids during pregnancy to birth outcomes have been documented. High maternal TG and low maternal high-density lipoproteincholesterol (HDL-C) have been associated with a higher birth weight z score and subsequently, macrosomia (3) (4) (5) . Few studies, however, have examined this relation to longer-term outcomes. Daraki et al. (6) observed that an increase of 1 mmol/L in maternal cholesterol was associated with a greater offspring skin-fold thickness at 4 years of age after adjustment for a number of confounders. In a large prospective study, an association was observed between maternal total cholesterol and offspring fat percentage at 5 years (7) . Such an association, if present, would lend further support to the presence of developmental programming in the offspring, based on fuel-mediated teratogenesis.
The aim of this study was to examine the association between maternal lipids during pregnancy and later, offspring adiposity at age 5 to 7 years, controlled for relevant confounders, including maternal body mass index (BMI), gestational glycemia, and offspring birth weight.
Materials and Methods
Details of the methodology of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study have been published in Metzger et al. (8) and the HAPO Study Cooperative Research Group (9) . In brief, the HAPO study was a 15-center multicultural and multinational study designed to examine the association between maternal hyperglycemia and adverse pregnancy outcomes with singleton pregnancies in which the results on an oral glucose tolerance test (OGTT) were below the thresholds for diabetes. All pregnant women at a given center were eligible to participate. Each participant underwent a standard 75-g OGTT between 24 and 32 weeks' gestation (optimal, 28 weeks), with sampling of plasma glucose fasting and at 1 hour and 2 hours. OGTT results were blinded to the clinician responsible for the care of the pregnant woman unless the fasting plasma glucose level exceeded 5.8 mmol/L or the 2-hour postload level exceeded 11.1 mmol/L. A number of standardized questionnaires were used to determine information about the mother, including age at OGTT, prepregnancy BMI, marital status, and years in education. All eligible women from the Belfast center were invited to take part in a prospective observational study involving an additional fasting serum sample for lipids at 28 weeks' gestation and long-term follow-up of their HAPO offspring. Offspring from these pregnancies had anthropometric measurements performed within 72 hours of birth.
Mothers were contacted 5 to 7 years after birth and invited to participate in a follow-up study for both the mother and the offspring. Similar questionnaires were used at follow-up to determine information about the mother. Anthropometric measurements obtained in the offspring included weight (to the nearest 0.1 kg; scale model 708; Seca, Birmingham, UK); height (to the nearest 0.1 cm using a calibrated stadiometer); head circumference (standard plastic measuring tape); and skin-fold thicknesses at triceps, subscapular, and suprailiac sites (Holtain, Crymych, UK). Two measurements were made, and if results differed by more than a prespecified amount, then a third was done. In that case, if two of three measurements differed by less than the prespecified amount, then the average of those two was used; otherwise, the average of all three was used. These skinfold measurements were added to give a summary measure of subcutaneous fat.
For these analyses, the average of the two measurements was used, unless a third measurement was taken. In that case, if two of the three measurements differed by less than the prespecified amount, then the average of those two was used; otherwise, the average of all three was used.
Offspring weight, height, head circumference, and BMI were also converted to a SD score using the 1990 British growth standard (10) . Offspring physical activity was measured for 7 days using an Actigraph GT1M accelerometer and analyzed using Actilife Software v6 13.3 (Actigraph Inc., Pensacola, FL). An accelerometery record was considered valid if it contained at least 4 valid days of data, and 1 day was considered valid if the device was worn for at least 10 hours in the day (11). Freedson cut-off points were used to calculate time spent in moderate or vigorous activity each day (12) , and the average steps/day were also extracted. Data from the accelerometer were used to calculate if a child was physically active/inactive. Physically active was defined as moderate-to-vigorous physical activity (MVPA) as $60 min/d and inactive as ,60 minutes of MVPA/d, per recommended guidelines (13) . Offspring dietary intakes were calculated from a 4-day weighed food diary using the nutritional software package Q-Builder (Questionnaire Design System), version 2.0 (Tinuviel Software, Anglesey, UK), which uses UK food composition tables to quantify nutrient intakes.
Serum lipids (total cholesterol, TG, and HDL-C) and plasma glucose levels were measured using a chemical analyzer (Roche C6000; Roche Diagnostics, GmbH, Penzburg, Germany). Lowdensity lipoprotein cholesterol (LDL-C) was derived using the Friedewald equation if TG levels did not exceed 4.52 mmol/L. The intra-assay coefficients of variation for cholesterol, HDL, and TGs were, on average, 1.3%, 0.7%, and 0.8%, respectively. The interassay coefficients of variation for cholesterol, HDL, and TGs were, on average, 2.0%, 2.7%, and 2.0%, respectively.
Based on BMI at the pregnancy OGTT, mothers were classified as obese (BMI $ 33 kg/m 2 ), overweight (BMI 28.5 to 32.9 kg/m 2 ), or normal weight (BMI , 28.5 kg/m 2 ), per previously reported cut-offs for BMI categories in late pregnancy (14) . Offspring birth weight and BMI at 5 to 7 years were converted to a SDS z score, using the age-and gender-specific 1990 British growth standard (10) . A summary skin-fold thickness measure was derived as the sum of skin folds (SSFs) from each of the measured sites at 5 to 7 years of age. Adiposity at birth was evaluated by birth weight z score and using birth weight z score $90th percentile to define large for gestational age. At 5 to 7 years, the measures of offspring adiposity included BMI z score, BMI z score $85th (overweight or obese) and $95th (obese) percentile, offspring SSF, and SSF $90th percentile.
Statistical analysis
Statistical analyses were performed using SPSS 24 (IBM Corp., Armonk, NY). Baseline characteristics are presented as means (6SD) or proportions and categorized by offspring at 6 year BMI z score, with independent samples t test or x 2 test. For analysis using continuous variables, the distribution of SSFs and maternal TG showed positive skew, and these were logarithmically transformed and summarized as the geometric means and interquartile range. Correlation analysis was used to examine the crude relationship between variables. The association between maternal lipids and offspring categorical outcomes was examined using logistic regression, with and without adjustment for the selected variables. The logistic regression used a number of models: model 1, birth weight z score, offspring age, offspring gender, smoking during pregnancy, offspring energy intake, and offspring physical activity behavior; model 2, model 1 plus maternal BMI at OGTT; and model 3, model 2 and maternal fasting plasma glucose at 28 weeks' gestation. To allow for the multitude of statistical analyses, a stricter significance level of P , 0.01 was adopted for all linear and logistic regression analyses, whereas the conventional level of P , 0.05 was used for comparison of baseline participant characteristics.
Ethical approval was obtained from the Northern Ireland Regional Ethics Committee, and the research adhered to the tenets of the Declaration of Helsinki.
Results
Recruitment and follow-up numbers from the Belfast HAPO center are presented in Supplemental Fig. 1 . The number of participants was slightly reduced in some analyses, as a result of unavailability of LDL-C in 21 mothers and SSF in6 children. Table 1 shows the maternal and offspring characteristics by offspring BMI z score (,0.00 vs .0.00) at 5 to 7 years. As expected, maternal BMI at 28 weeks' gestation was significantly different across the two subgroups (27.1 6 3.9 vs 28.7 6 4.5, P # 0.001). Women were more likely to be obese during pregnancy whose offspring had a BMI z score .0.00 at 5 to 7 years compared with #0.00 (75.3% vs 24.7%; #0.001). No significant differences were observed in maternal lipid biomarkers between the two offspring BMI z score groups. In terms of offspring characteristics, birthweight z score (20.4 6 0.9 vs 0.0 6 0.9, P # 0.001) and SSF thickness [1.3 (1.2 to 1.3) vs 1.4 (1.3 to 1.5), P = 0.004] were significantly different between the two subgroups of BMI z scores. These associations were also observed in the offspring at the 5-to 7-year follow-up. There were no significant differences between the level of physical activity done and dietary markers between the two subgroups (all P . 0.05).
There was no discernible relationship between maternal serum lipids during pregnancy (total cholesterol, TG, LDL-C, HDL-C) and offspring BMI z score at a 5-to 7-year follow-up on scatterplots and correlation analysis. A similar lack of association was observed between maternal lipids and offspring SSFs at 5 to 7 years of age, both on scatterplots. Table 2 shows the association of three measures of excess offspring adiposity at follow-up with each of the maternal lipid measures using unadjusted and adjusted logistic regression analysis. Following adjustment for a number of confounding variables, including dietary and physical activity data, no significant associations were observed between maternal lipids and offspring measures of adiposity. The above lipid analyses were repeated and stratified, according to BMI at OGTT categories, and regression analyses were repeated per Table 2 with the same confounding variables, with the exception of the removal of BMI at OGTT, as a result of stratification by the same variable. No significant associations were observed between the various weight categories with maternal lipids and offspring adiposity outcomes (data not shown).
Discussion
In this carefully characterized cohort and after controlling for relevant confounding variables, we found no association between any of the measured maternal lipids during pregnancy and later, offspring adiposity.
Obesity is generally thought to be the result of a combination of nature and nurture, but a specific intrauterine influence has increasingly been recognized (12, 13) . In this regard, the relationship between maternal gestational lipids and later, offspring obesity is of considerable interest. There is a physiological rise in maternal lipids during pregnancy that starts around midsecond trimester, reaching its peak in the third trimester (15) . One putative mechanism may relate to the delivery of energy excess to the offspring from the energy-rich TGs that have previously been related to excess offspring birth weight (16) . However, we are unable to support this finding, as we found no relation between fasting maternal TG and offspring obesity risk at 5 to 7 years of age. We also found a similar lack of association between b n = 747 for models, including LDL-C.
c n = 743 for models, including LDL-C.
hyperglycemia during pregnancy, the principal maternofetal fuel, and later offspring obesity, as previously reported using data from the same cohort (17) . We are aware of few previous human studies that have directly examined these relationships. One study examined patients with familial hypercholesterolemia, inherited either maternally or paternally, and reported primarily on lipid differences between the two groups in adult offspring (18 to 85 years) (18) . Like us, the authors found no difference in mean BMI between the groups, even though offspring with maternal inheritance would be expected to experience a significantly greater hypercholesterolemic intrauterine milieu. A community-based study of Amsterdam-born children observed that maternal TGs were only significantly related to waist/height ratio, independent of confounders, whereas the association with offspring body fat percentage and BMI became nonsignificant after adjustment for confounders (7) . The authors concluded that there was no convincing proof for mediation by the maternal lipid profile during early gestation. Daraki and colleagues (6) examined early pregnancy measures of maternal lipids and the associations with offspring adiposity measures in 348 offspring aged 4 years. They observed that an increase of 1.00 mmol/L in fasting serum cholesterol levels was associated with a 3.30 (95% CI: 1.41, 5.20)-mm greater skin-fold thickness at 4 years of age in adjusted analysis (6) . It is unclear why the results of the latter study differ from those of the current study, although of note is the fact that subject numbers in that study were relatively small (n = 348). The current study has a large number of participants (n = 760), and it was performed in a carefully characterized cohort with a high followup rate. Streamlined methods for the measurement of neonatal anthropometry and analysis of maternal lipids were performed throughout the study. In addition, the mothers who participated in the HAPO study, who were retrospectively diagnosed with gestational diabetes mellitus (per International Association of Diabetes and Pregnancy Study Groups guidelines), were left untreated following diagnosis. This allows assessment of the relationships without impact from glucose-lowering interventions during pregnancy. The regression analysis in the current study contained a large number of confounders, including offspring energy intake and physical activity, as determined by a 4-day food diary and accelerometery data.
There are some limitations to our data. Firstly, unlike placental glucose transfer, transfer of both maternal cholesterol and TGs is more complex and regulated by enzymatic systems. It is currently unclear whether such processes display heterogeneity in materno-fetal lipid transfer, independent of maternal lipids. Whereas further evidence is awaited, we have interpreted our results on the assumption that maternal hyperlipidemia will reflect proportionally on the fetal milieu. Furthermore, the current study is confined to women of white European origin, and therefore, the data need to be extrapolated with caution to other population groups and to other offspring ages. There also may be an additional rise in maternal lipids after 28 weeks' gestation, which may have a larger impact on offspring obesity. There is also a possibility that older participants in this follow-up study at 5 to 7 years may already have physiological adrenarche, and we were unable to control for this confounding variable.
In summary, this study shows that maternal thirdtrimester lipids are not associated with an increased risk for offspring obesity by age 5 to 7 years. Whether such a relation exists in older offspring is unknown, but a similar long-term follow-up study is currently in progress among 8-to 12-year-old HAPO offspring in the Belfast center.
